找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunotherapy; Aung Naing,Joud Hajjar Book 2021Latest edition The Editor(s) (if applicable) and The Author(s), under exclusive license to

[復(fù)制鏈接]
樓主: 選民
21#
發(fā)表于 2025-3-25 04:16:48 | 只看該作者
22#
發(fā)表于 2025-3-25 11:25:21 | 只看該作者
Abdulrazzak Zarifa,Juan Lopez-Mattei,Nicolas L. Palaskas,Cezar Iliescu,Jean-Bernard Durand,Peter Y. tinued to be the case despite recent advances in the treatment of acute events, which have proven to decrease disability and improve outcomes. Over recent years, there has been significant growth in the field of acute stroke care and stroke systems of care. This includes improvements in the manageme
23#
發(fā)表于 2025-3-25 14:22:34 | 只看該作者
24#
發(fā)表于 2025-3-25 17:57:31 | 只看該作者
25#
發(fā)表于 2025-3-25 23:54:47 | 只看該作者
Immunotherapy for Melanoma,n, we provide an overview of the results of recent advances in the adjuvant setting for patients with resected stage III and stage IV melanoma, as well as in patients with melanoma brain metastases. Finally, we provide a brief overview of the current research efforts in the field of immuno-oncology for melanoma.
26#
發(fā)表于 2025-3-26 00:16:11 | 只看該作者
27#
發(fā)表于 2025-3-26 07:50:37 | 只看該作者
Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity,toxicities related to immunotherapy are reportedly rare, they can be severe and associated with life-threatening conditions such as fulminant myocarditis, hemodynamic instability, and cardiac arrest. We will review the most commonly reported cardiovascular toxicities associated with ICIs and their management.
28#
發(fā)表于 2025-3-26 08:36:35 | 只看該作者
29#
發(fā)表于 2025-3-26 13:16:06 | 只看該作者
Resistance to Immunotherapy: Mechanisms and Means for Overcoming,rucial to understand the pathophysiology of the tumor-immune system interplay and the mechanisms of immune escape in order to circumvent primary and acquired resistance. Here we provide an outline of the most well-defined mechanisms of resistance and shed light on ongoing efforts to reinvigorate immunoreactivity.
30#
發(fā)表于 2025-3-26 16:49:46 | 只看該作者
Renal Toxicity, autoimmune disease with a focus on renal cell cancer in setting of chronic kidney disease (CKD). Transplant rejection in setting of CPI use has been further evaluated with single-center and multicenter retrospective studies, and available data will be presented in this chapter.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 09:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
金寨县| 邢台县| 新巴尔虎右旗| 通榆县| 聂荣县| 确山县| 抚顺县| 马尔康县| 吴旗县| 南丹县| 天峨县| 上高县| 巴林左旗| 宝清县| 扶风县| 玉山县| 秭归县| 襄垣县| 青河县| 巴里| 武夷山市| 镇赉县| 仙游县| 嵊州市| 吉木萨尔县| 隆德县| 克什克腾旗| 永和县| 明光市| 宣恩县| 莫力| 巩义市| 和静县| 阳山县| 广灵县| 荆门市| 隆安县| 红原县| 怀安县| 会昌县| 泸定县|